QA: Neuropathix INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001615999_2022_Neuropathix_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001615999, Neuropathix INC

  xvar xval
0 AssetsCurrent 138,390
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 69,192
3 remainder_Assets 17,121
4 LiabilitiesCurrent 2,983,027
5 LiabilitiesNoncurrent 1,228,431
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,672,334
9 ResearchAndDevelopmentExpense 451,779
10 remainder_Expenses 0
11 remainder_Revenues 183,477
12 remainder_NetIncome -617,150
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 224,703
1 Liabilities 4,211,458
2 Expenses 3,124,113
3 Revenues 183,477
4 StockholdersEquity -3,986,755
5 NetIncome -3,557,786
6 ComprehensiveNetIncome -3,557,786
7 BaseVar 4,180,450
8 EconomicCapitalRatiobeforeLimitedLiability -5.52
9 EconomicCapitalRatio 0.123

Edgar->Model Mapping

Feature Distribution

Change over Time